AdrenoMed Receives FDA Fast Track for Enibarcimab in Septic Shock
10 Apr 2024 //
GLOBENEWSWIRE
Adrenomed presents new findings on its precision medicine treatment
08 Sep 2023 //
GLOBENEWSWIRE
Adrenomed receives EMA’s advice for clinical development of Adrecizumab
06 Dec 2021 //
PHARMABIZ